Aadi bioscience appoints david dornan, phd, as chief scientific officer

Seasoned oncology leader brings extensive adc expertise to support company's new pipeline morristown, n.j. , feb. 18, 2025 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi) today announced the appointment of david dornan, phd as the company's chief scientific officer (cso).
AADI Ratings Summary
AADI Quant Ranking